This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics Europe

ONLINE REGISTRATION CLOSES IN:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
Delivered as a Hybrid Event, 7 - 9 June, 2022
Live In-Person Event: 7 - 9 June, Postillion Hotel AmsterdamDigital Experience: All Sessions Livestreamed 7 - 9 June

Michael Singer, MD, PhD
Co-Founder, CSO and Director at Cartesian Therapeutics

Profile

Michael Singer is Chief Scientific Officer at Cartesian Therapeutics, a clinical-stage biotech developing RNA cell therapies in and beyond oncology. He has co-founded three life sciences companies. Previously, he led development teams for three different monoclonal antibodies at Novartis. Dr. Singer holds a BS, MD, and PhD from Yale University, where he serves on the external faculty, and completed internship and residency at Harvard Medical School.

Agenda Sessions

  • RNA-Engineered Cell Therapies for Autoimmune Disease

    16:55